Uploaded October 2025 | Updated September 2026, 2 weeks ago
Caitlyn Krebs is a biotech executive with over 20 years of experience advancing therapeutics, diagnostics, and digital health innovations. She is the Co-Founder and CEO of Nalu Bio, where she leads the development of next-generation cannabinoid-inspired therapeutics with pharmaceutical-grade quality and scalability. #shorts #endometriosis #womenshealth
Over her career, Caitlyn has completed more than 50 strategic partnerships and product launches across biopharma, diagnostics, and digital health.
Nalu Bio recently announced positive results for a cannabinoid-based therapeutic for endometriosis, a condition that affects 200 million women worldwide.
Watch Now: youtu.be/Bq28bTdc1WY
During our conversation, we discussed:
⦿ Understanding Endometriosis - symptoms, diagnosis, and current treatment options
⦿ How Millions of women with endometriosis are using CBD or THC to self-treat symptoms
⦿ What makes the endocannabinoid system a prime target for for endometriosis
⦿ How Nalu Bio uses an AI platform to accelerate the development of novel, consistent, and non-addictive cannabinoid molecules
⦿ The potential for broader applications for cannabinoid-based therapeutics, similar to GLP-1 therapies
⦿ The timeline for future clinical trials and potential FDA-approval
Thanks to This Episode’s Sponsor: @societyofcannabisclinicians
Caitlyn Krebs is a biotech executive with over 20 years of experience advancing therapeutics, diagnostics, and digital health innovations. She is the Co-Founder and CEO of Nalu Bio, where she leads the development of next-generation cannabinoid-inspired therapeutics with pharmaceutical-grade quality and scalability. #shorts #endometriosis #womenshealth
Over her career, Caitlyn has completed more than 50 strategic partnerships and product launches across biopharma, diagnostics, and digital health.
Nalu Bio recently announced positive results for a cannabinoid-based therapeutic for endometriosis, a condition that affects 200 million women worldwide.
Watch Now: youtu.be/Bq28bTdc1WY
During our conversation, we discussed:
⦿ Understanding Endometriosis - symptoms, diagnosis, and current treatment options
⦿ How Millions of women with endometriosis are using CBD or THC to self-treat symptoms
⦿ What makes the endocannabinoid system a prime target for for endometriosis
⦿ How Nalu Bio uses an AI platform to accelerate the development of novel, consistent, and non-addictive cannabinoid molecules
⦿ The potential for broader applications for cannabinoid-based therapeutics, similar to GLP-1 therapies
⦿ The timeline for future clinical trials and potential FDA-approval
Thanks to This Episode’s Sponsor: @societyofcannabisclinicians
